Research Article |
Corresponding author: Muhamad Insanu ( insanu@fa.itb.ac.id ) Academic editor: Rumiana Simeonova
© 2022 Septriyanto Dirgantara, Muhamad Insanu, Irda Fidrianny.
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Citation:
Dirgantara S, Insanu M, Fidrianny I (2022) Evaluation of xanthine oxidase inhibitory, antioxidative activity of five selected Papua medicinal plants and correlation with phytochemical content. Pharmacia 69(4): 965-972. https://doi.org/10.3897/pharmacia.69.e91083
|
Some medicinal plants from Papua have been used traditionally as hyperuricemia and antioxidant agents for many ethnic in Papua Islands. The present study aims to evaluate inhibitory xanthine oxidase, antioxidative activities, total phenolic, and total flavonoid of five Papua selected medicinal plants, Myrmecodia beccarii, Villebrunea rubescens, Breynia cernua, Bridelia spp. and Dodonaea viscosa. Preliminary phytochemical screening revealed the presence of flavonoids and phenolic compounds with TLC-densitometric analysis, which is responsible for the biological activities of different plant extracts. Antioxidant was tested by 2,2- diphenyl-1- picrylhydrazyl (DPPH) and cupric ion antioxidant capacity (CUPRAC) methods and expressed as the Antioxidant Activity Index (AAI). Xanthine oxidase inhibitory (XOI) activity was evaluated by a spectrophotometer. The ethyl acetate of Myrmecodia beccarii extract (MEA) showed the highest antioxidative and XOI activity. The MEA extract from Papua may be developed as a new potential source of antioxidant and xanthine oxidase inhibitory agent.
Papua, medicinal plants, xanthine oxidase, antioxidant, the phytochemical content
Several Papua plants, such as Myrmecodia beccarii Hook. f, Villebrunea rubescens (Bl), Breynia cernua Muel. Arg, Bridelia spp., and Dodonaea viscosa Jacq. have long been used as medicinal plants by the Papuan people. Traditionally, local people in the Papua Province, Indonesia, have shared important information about medicinal plants in their communities to treat illness and various diseases, especially uric acid and gout therapies. The xanthine oxidase enzyme catalyzes the oxidation of xanthine to uric acid and hypoxanthine to xanthine. The oxidation produces superoxide radicals like hydrogen peroxide and reactive oxygen species (ROS) (
Xanthine oxidase inhibitors (XOI) will block the concluding step in uric acid biosynthesis that can reduce the plasma uric acid concentration level and are commonly applied for the treatment of gout (
The previous study only demonstrated the plants’ ecology, taxonomy, and preliminary ethnopharmacological studies. Limited papers discussed the biological activities and the phytochemical content of Papua endemic medicinal plants. The potential active compound possessed by some plants from Papua, as well as their biological activity, is unknown. It is necessary to investigate XOI and antioxidative activities. This research aimed to evaluate XOI and antioxidative activities from five selected medicinal plants from Papua and to analyze their correlation with phytochemical content.
Xanthine, xanthine oxidase, 2,2-diphenyl-1-picrylhydrazyl (DPPH), quercetin, gallic acid, cupric chloride, and neocuproine were obtained from Sigma-Aldrich Chemicals (St. Louise, MO, USA). The ascorbic acid was obtained from Merck (Darmstadt, Germany). Allopurinol was purchased from TCI (Tokyo, Japan), and all other reagents were analytical grade.
Fresh aerial parts of five selected medicinal plants, Myrmecodia beccarii Hook.f, Villebrunea rubescens (Bl), Breynia cernua Muel. Arg, Bridelia spp. and Dodonaea viscosa Jacq. were collected from five different locations in Papua Province-Indonesia and determined in the Herbarium of Research Center for Biology-Indonesian Institute of Sciences listed in Table
Collection sample of selected medicinal plants from Papua region-Indonesia.
Scientific name | Local name | Sample location | Part(s) used | Family |
---|---|---|---|---|
Myrmecodia beccarii Hook.f | Sarang semut | Merauke | Tuber | Rubiaceae |
Villebrunea rubescens (Bl) | Daun jilat | Serui | Leaves | Urticaceae |
Breynia cernua Muel. Arg | Katuk hutan | Jayapura | Leaves | Euphorbiaceae |
Dodonaea viscosa Jacq. | Dollu | Lanny Jaya | Leaves | Sapindaceae |
Bridelia spp. | Sampare | Biak | Leaves | Phyllanthaceae |
Extraction was conducted using Soxhlet with increasing polarity solvent, ranging from nonpolar (n-hexane), semi-polar (ethyl acetate), and polar solvent (96% ethanol). Crude drug powder 100 grams of five medicinal plants from Papua, Myrmecodia beccarii Hook.f, Villebrunea rubescens (Bl), Breynia cernua Muel. Arg, Bridelia spp., and Dodonaea viscosa Jacq. were extracted with n-hexane, and the filtrate and residue were then separated. The residue was dried and extracted with ethyl acetate. Finally, the residue was extracted using 96% ethanol. All extracts were evaporated using a rotary vacuum evaporator with a temperature of 50 °C to produce fifteen extracts. There were five n-hexane extracts (M. beccarii (MBH), V. rubescens (VRH), B. cernua (BCH Bridelia spp. (BSH), and n-hexane extract of D. viscosa (DVH)); five ethyl acetate extract (M. beccarii (MEA), V. rubescens (VEA), Breynia cernua (BEA), Bridelia spp. (BSE) and ethyl acetate extract of D. viscosa (DEA)) and five ethanol extract (M. beccarii (MET); V. rubescens (VET), B. cernua (BCE), Bridelia spp. (BET) and ethanolic extract of D. viscosa (DET)). The phytochemical test was performed on crude drugs and extracts using the method described in Farnsworth and Sarker’s modified method (
The total phenolic content was evaluated with a Folin-Ciolcalteu reagent adapted to Pourmorad’s method (
The total content of flavonoids was measured using an adapted method from Chang (
Determination of the AAI (Antioxidant Activity Index) based on Blois’s method (
The AAI (Antioxidant Activity Index) CUPRAC was determined based on Apak’s method (
The inhibitory activity of xanthine oxidase was measured by spectrophotometer in 96-well plates (Corning, UV-Transparent Clear Microplates) below the aerobic conditions, following the method reported by Owen and Duong with some minor modification (Owen and John 1999;
TLC-densitometric studies were carried out using the standard method by Wagner (
The results were the means ± SD of at least three independent tests, using MS Excel Software to evaluate the IC50 and EC50 values. Analysis of the statistic (one-way ANOVA – post hoc Tukey) was carried out by SPSS 23. Using Pearson’s method, correlations were made between the total phenolic and flavonoid content with antioxidant and xanthine oxidase inhibitory activities.
In the present investigation, antioxidative activity, total phenolic and flavonoid content, xanthine oxidase inhibitory activities of five medicinal plants from Papua, M. beccarii, V. rubescens, B. cernua, Bridelia spp., and D. viscosa were evaluated. Extraction was carried out by Soxhlet with different polarity solvents, three solvents n-hexane, ethyl acetate, and ethanol. Three other polarities solvents, such as n-hexane, ethyl acetate, and ethanol, were used to separate based on the polarity of compounds in crude drugs. n-hexane and ethyl acetate were selected solvents. Therefore, the nonpolar compounds will be mainly extracted in n-hexane and semipolar compounds in ethyl acetate. Meanwhile, ethanol will find most of the polar compounds. The extracts’ preliminary qualitative investigation revealed phytochemical compounds such as alkaloids, flavonoids, triterpenoids/steroids, quinone, saponin, tannin, and phenols. The phytochemical screening results were carried out from each extract of the Soxhlet extraction method using increasing polarity solvents from five plants M. beccarii, V. rubescens, B. cernua, Bridelia spp., and D. viscosa were displayed in Table
Sample | Phytochemical screening | |||||||
---|---|---|---|---|---|---|---|---|
Alkaloid | Flavonoid | Steroid/ Triterpenoid | Quinone | Saponin | Tannin | Phenols | ||
MB | CD | - | + | + | + | + | + | + |
MBH | - | - | + | - | - | - | - | |
MEA | - | + | + | + | + | + | + | |
MET | - | + | - | - | + | + | + | |
VR | CD | + | + | + | - | - | + | + |
VRH | - | + | + | - | - | - | - | |
VEA | + | + | + | - | - | - | + | |
VET | - | - | - | - | - | + | - | |
BC | CD | + | + | + | - | + | + | + |
BCH | - | - | + | - | - | - | - | |
BEA | + | + | - | - | - | + | + | |
BCE | - | + | - | - | + | + | + | |
BS | CD | + | + | + | + | + | + | + |
BSH | - | - | + | - | - | - | - | |
BSE | + | + | + | + | - | - | - | |
BET | - | + | - | - | + | + | + | |
DV | CD | + | + | + | - | + | + | + |
DVH | - | - | + | - | - | - | - | |
DEA | + | + | - | - | - | + | + | |
DET | + | + | - | - | + | + | + |
Density is a crucial assay to compare its activity and phytochemistry compound levels. Higher density will result in stronger activity and phytochemical content. The measurement of the concentrated extract was carried out using a 1% extract solution in a pycnometer. In this study, the density of each extract showed values in the range of 0.661–0.895 g/mL.
In determining the TPC in each extract based on Table
Sample | Yield (%) | The density of extract 1% (g/mL) | TPC g GAE/100 g | TFC g QE/100 g |
---|---|---|---|---|
MBH | 3.41 | 0.661 | 5.37 ± 0.16a | 1.22 ± 0.13a |
MEA | 9.12 | 0.780 | 7.92 ± 0.24b | 2.80 ± 0.04b |
MET | 19.15 | 0.895 | 4.41 ± 0.16c | 1.67 ± 0.03c |
VRH | 6.75 | 0.665 | 7.14 ± 0.18d | 2.93 ± 0.02b |
VEA | 5.29 | 0.673 | 2.40 ± 0.29e | 2.40 ± 0.02d |
VET | 8.84 | 0.784 | 3.43 ± 0.07f | 2.63 ± 0.04b |
BCH | 6.35 | 0.758 | 4.08 ± 0.18c | 2.30 ± 0.01d |
BEA | 11.62 | 0.857 | 7.09 ± 0.11g | 3.08 ± 0.01e |
BCE | 22.53 | 0.893 | 9.01 ± 0.23h | 0.99 ± 0.02f |
BSH | 2.85 | 0.697 | 6.07 ± 0.18i | 2.49 ± 0.01d |
BSE | 3.79 | 0.722 | 8.42 ± 0.17b | 8.03 ± 0.02g |
BET | 30.13 | 0.898 | 6.92 ± 0.18j | 3.30 ± 0.02h |
DVH | 9.27 | 0.767 | 4.53 ± 0.07k | 1.52 ± 0.02c |
DEA | 17.17 | 0.866 | 5.77 ± 0.06l | 4.98 ± 0.05i |
DET | 22.93 | 0.894 | 3.12 ± 0.17m | 0.89 ± 0.02f |
Based on Table
Sample | IC50 DPPH (µg/mL) | AAI DPPH | EC50 CUPRAC (µg/mL) | AAI CUPRAC |
---|---|---|---|---|
MBH | 182.80 ± 1.79a | 0.14 ± 0.01a | 152.39 ± 1.32a | 0.33 ± 0.01a |
MEA | 7.82 ± 0.65b | 3.22 ± 0.26b | 11.73 ± 0.45b | 4.27 ± 0.16b |
MET | 29.93 ± 0.64c | 0.84 ± 0.02c | 109.66 ± 0.98c | 0.46 ± 0.01c |
VRH | 174.17 ± 1.64d | 0.14 ± 0.01d | 223.90 ± 1.72d | 0.22 ± 0.01d |
VEA | 187.08 ± 2.66f | 0.13 ± 0.01f | 184.83 ± 1.07e | 0.27 ± 0.01e |
VET | 212.23 ± 1.87d | 0.12 ± 0.01d | 148.29 ± 0.89f | 0.34 ± 0.01f |
BCH | 137.16 ± 1.68e | 0.18 ± 0.01e | 80.63 ± 2.18g | 0.62 ± 0.02g |
BEA | 88.93 ± 1.56g | 0.28 ± 0.01g | 136.94 ± 0.57h | 0.37 ± 0.01h |
BCE | 33.25 ± 0.83c | 0.75 ± 0.02c | 44.27 ± 0.28i | 1.13 ± 0.01i |
BSH | 171.98 ± 3.76d | 0.15 ± 0.01d | 103.69 ± 0.40j | 0.48 ± 0.01j |
BSE | 11.86 ± 1.91b | 2.17 ± 0.37b | 36.04 ± 0.27k | 1.39 ± 0.01k |
BET | 34.69 ± 0.99c | 0.72 ± 0.02c | 25.71 ± 0.57l | 1.95 ± 0.05l |
DVH | 135.89 ± 1.06e | 0.18 ± 0.01e | 60.71 ± 0.24m | 0.83 ± 0.01m |
DEA | 35.28 ± 0.70i | 0.71 ± 0.01i | 22.05 ± 0.19n | 2.27 ± 0.02n |
DET | 16.51 ± 0.96h | 1.52 ± 0.09h | 27.75 ± 0.05l | 1.80 ± 0.01l |
Ascorbic Acid | 2.45 ± 0.02 | 10.20 ± 0.10 | 4.19 ± 0.10 | 11.92 ± 0.29 |
A recent study (
Based on Table
Antioxidant Parameter | Pearson’s Correlation Coefficient (r) | |
---|---|---|
TPC | TFC | |
AAI DPPH MB | 0.880** | 0.986** |
AAI DPPH VR | 0.636* | 0.497ns |
AAI DPPH BC | 0.889** | 0.850** |
AAI DPPH BS | 0.976** | 0.959** |
AAI DPPH DV | -0.618* | -0.261ns |
AAI CUPRAC MB | 0.952** | 0.961** |
AAI CUPRAC VR | -0.669* | -0.471ns |
AAI CUPRAC BC | 0.557ns | -0.998** |
AAI CUPRAC BS | 0.473ns | 0.269ns |
AAI CUPRAC DV | 0.284ns | 0.648* |
The correlation between two antioxidant testing DPPH and CUPRAC methods has also been exposed in Table
Antioxidant Parameter | Pearson’s Correlation Coefficient (r) | ||||
---|---|---|---|---|---|
AAI CUPRAC MB | AAI CUPRAC VR | AAI CUPRAC BC | AAI CUPRAC BS | AAI CUPRAC DV | |
AAI DPPH MB | 0.973** | ||||
AAI DPPH VR | -0.932** | ||||
AAI DPPH BC | 0.883** | ||||
AAI DPPH BS | 0.390ns | ||||
AAI DPPH DV | 0.563ns |
Based on Fig.
TLC-densitometric analysis showed that ethyl acetate extract of M. beccarii extract (MEA) revealed the presence of various phytochemical contents, as illustrated the Fig.
Peak | Maximum Rf | Area | % Area | Assigned Substance |
---|---|---|---|---|
1 | 0,23 | 2165,4 | 4,08 | unknown |
2 | 0,28 | 1505,7 | 2,83 | unknown |
3 | 0,38 | 5546,8 | 10,83 | unknown |
4 | 0,50 | 406,8 | 0,77 | unknown |
5 | 0,58 | 715,3 | 1,35 | unknown |
6 | 0,69 | 3703,4 | 6,97 | unknown |
7 | 0,82 | 27374,2 | 51,52 | Caffeic acid |
8 | 0,92 | 11380,8 | 21,65 | unknown |
The research results showed that each extract of the Papua medicinal plants plant gave a different pattern of xanthine oxidase inhibitory and antioxidative activity depending on the solvent used. This can be due to the other chemical content in every fifteen extracts. According to the result, it can be presumed that the total phenolic content of extracts contributed to its antioxidative activity and xanthine oxidase inhibitory activity.
The present results showed that all fifteen Papua medicinal plant extracts had a variety of xanthine oxidase inhibitory, antioxidative activity, and phytochemical content. Total phenolic and flavonoid content of ethyl acetate extract of M. beccarii (MEA) gave a significant and positive linear correlation with AAI DPPH and CUPRAC assays and xanthine oxidase inhibitory activity. Phenolic and flavonoid compounds in M. beccarii extract significantly contributed to the antioxidative activity and XOI. The ethyl acetate of M. beccarii (MEA) originated from Papua and may be developed as a potential source of new antioxidant and xanthine oxidase inhibitory agent.
The authors thank the Ministry of Education, Culture, Research and Technology for financial support for Domestic Postgraduate Education (BPPDN) scholarships, the World-Class Research grant 2021 for research funding, and the School of Pharmacy Bandung Institute Technology for the research facilities.